Univ of Pittsburgh Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Univ of Pittsburgh Cancer Institute has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Prostatic Neoplasms, Prostatic Cancer, Castration-Resistant, Metastatic Pancreatic Ductal Adenocarcinoma.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Univ of Pittsburgh Cancer Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Univ of Pittsburgh Cancer Institute has 3 clinical trials on record, with 2 currently active. Their work covers Prostatic Neoplasms, Prostatic Cancer, Castration-Resistant, Metastatic Pancreatic Ductal Adenocarcinoma.
Univ of Pittsburgh Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.